Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple-Dose Phase I and Pharmacokinetic Trial of Perillyl Alcohol

NCT00022425 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00022425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00022425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple-Dose Phase I and Pharmacokinetic Trial of Perillyl Alcohol
Lead sponsor
The Cleveland Clinic
Phase
Phase 1
Overall status
Unknown status
Start date
June 30, 2001
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer